Optimization of skin permeation and distribution of ibuprofen by using nanostructures (coagels) based on alkyl vitamin C derivatives

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 76, Issue 3, 2010, Pages 443-449

  Saino, V ^a   Monti, D ^a   Burgalassi, S ^a   Tampucci, S ^a   Palma, S ^b   Allemandi, D ^b   Chetoni, P ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Coagel; Ex vivo skin permeation; Ibuprofen; Rat skin; Skin distribution; Transdermal

Indexed keywords

ASCORBIC ACID DERIVATIVE; ASCORBYL LAURATE; ASCORBYL PALMITATE; IBUPROFEN LYSINE; PEGADEMASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG DISTRIBUTION; DRUG FORMULATION; GEL; NONHUMAN; RAT; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASCORBIC ACID; DRUG DELIVERY SYSTEMS; IBUPROFEN; MALE; NANOSTRUCTURES; PERMEABILITY; POLYETHYLENE GLYCOLS; RATS; RATS, HAIRLESS; SKIN; SKIN ABSORPTION;

EID: 78549252716     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.08.004     Document Type: Article

References (56)

1. Touitou E. Drug delivery across the skin. Expert Opin. Biol. Ther. 2002, 2:723-733.
2. Hadgraft J. Dermal and transdermal delivery. Modified Release Drug Delivery Technology 2003, 471-480. Marcel Dekker Inc., NY. M.J. Rathbone, J. Hadgraft, M.S. Roberts (Eds.).
3. Brown M.B., Martin G.P., Jones S.A., Akomeah F.K. Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv. 2006, 13:175-187.
4. Trommer H., Neubert R.H. Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol. Physiol. 2006, 19:106-121.
5. Wertz P.W. Lipids and barrier function of the skin. Acta Derm. Venereol. 2000, Suppl. 208:7-11.
6. Coderech L., Lopez O., de la Maza A., Parra J.L. Ceramides and skin function. Am. J. Clin. Dermatol. 2003, 4:107-129.
7. Bouwstra J.A., Honeywell-Nguyen L.P., Gooris G.S., Ponec M. Structure of the skin barrier and its modulation by vesicular formulations. Prog. Lipid Res. 2003, 42:1-26.
8. Perlovich G.L., Kurkov S.V., Kinchin A.N., Bauer-Brandl A. Solvation and hydration characteristics of ibuprofen and acetylsalicylic Acid. AAPS PharmSci. 2004, 6(1). Article 3.
9. Busson M.J. Update on ibuprofen: review article. J. Int. Med. Res. 1986, 14:53-62.
10. Wood J. Osteoarthritis and its management. Pharm. J. 1999, 262:744-746.
11. Barry B.W. Methods for studying percutaneous absorption. Dermatological Formulations Percutaneous Absorption 1983, 234-295. Marcel Dekker Inc., New York. B.W. Barry (Ed.).
12. Lee C.K., Uchida T., Kitagawa K., Yagi A., Kim N.S., Goto S. Skin permeability of various drugs with different lipophilicity. J. Pharm. Sci. 1994, 83:562-565.
13. Guy R.H. Current status and future prospects of transdermal drug delivery. Pharm. Res. 1996, 13:1765-1769.
14. Naik A., Kalia Y.N., Guy R.H. Transdermal drug delivery: overcoming the skin's barrier function. Pharm. Sci. Technol. Today 2000, 3:318-326.
15. Otto A., Wiechers J.W., Kelly C.L., Hadgraft J., Du Plessis J. Effect of penetration modifiers on the dermal and transdermal delivery of drugs and cosmetic active ingredients. Skin Pharmacol. Physiol. 2008, 21:326-334.
16. Capuzzi G., Lo Nostro P., Kulkarni K., Fernandez J. Mixtures of stearoyl-6-O-ascorbic acid and α-tocoferol: a monolayer study at the gas/water interface. Langmuir 1996, 12:3957-3963.
17. Capuzzi G., Lo Nostro P., Kulkarni K., Fernandez J., Vincieri F. Interactions of 6-O-stearoylascorbic acid and vitamin K1 in mixed Langmuir films at the gas-water interface. Langmuir 1996, 12:5413-5418.
18. Capuzzi G., Kulkarni K., Fernandez J., Vincieri F., Lo Nostro P. Mixture of ascorbyl-stearate and vitamin D3: a monolayer study at the gas-water interface. J. Colloid Interface Sci. 1997, 186:271-279.
19. Palma S., Manzo R.H., Allemandi D., Fratoni L., Lo Nostro P. Coagels from ascorbic acid derivatives. Langmuir 2002, 18:9219-9224.
20. Palma S., Jiménez-Kairuz A., Fratoni L., Lo Nostro P., Manzo H.R., Allemandi D. Coagels from alkanoyl-6-O-ascorbic acid derivatives as drug carriers: structure and rheology. Il Farmaco 2003, 58:1271-1276.
21. Palma S., Maletto B., Lo Nostro P., Manzo H.R., Pistoresi-Palencia M., Allemandi D. Potential use of ascorbic acid based surfactants as skin penetration enhancers. Drug Dev. Ind. Pharm. 2006, 32:821-827.
22. n): properties and potential platform for drug delivery. Int. J. Pharm. 2007, 345:26-34.
23. Yalkowsky S.H. Solubilization by cosolvents. Solubility and Solubilization in Aqueous Media 1999, 180-235. Oxford University Press, New York. S.H. Yalkowsky (Ed.).
24. Rytting E., Lentz K.A., Chen X-Q., Qian F., Venkatesh S. A quantitative structure-property relationship for predicting drug solubility in PEG 400/water cosolvent systems. Pharm. Res. 2004, 21:237-244.
25. 5)enkephalin from a cubic phase of glyceryl monooleate. Int. J. Pharm. 2000, 204:137-144.
26. Gabiga H., Cal K., Janicki S. Effect of penetration enhancers on isosobide dinitrate penetration through rat skin from a transdermal therapeutic system. Int. J. Pharm. 2000, 199:1-6.
27. Ambrosi M., Lo Nostro P., Fratoni L., Dei L., Ninham D.W., Palma S., Manzo R.H., Allemandi D., Baglioni P. Water of hydration in coagels. Phys. Chem. Chem. Phys. 2004, 6:1401-1407.
28. Llabot J.M., Palma S., Manzo R.H., Allemandi D. Design of novel antifungal mucoadhesive films: part I. Pre-formulation studies. Int. J. Pharm. 2007, 330:54-60.
29. Schmook F.P., Meingassner J.G., Billich A. Comparison of human skin or epidermis model with human and animal skin in in-vitro percutaneous absorption. Int. J. Pharm. 2001, 215:51-56.
30. Godin B., Touitou E. Transdermal skin delivery: prediction for humans from in vivo, ex vivo and animal models. Adv. Drug Deliv. Rev. 2007, 59:1152-1161.
31. Huong S.P., Bun H., Fourneron J-D., Reynier J-P., Andrieu V. Use of various models for in vitro percutaneous absorption studies of ultraviolet filters. Skin Res. Technol. 2009, 15:253-261.
32. Monti D., Brini I., Tampucci S., Chetoni P., Burgalassi S., Paganuzzi D., Ghirardini A. Skin permeation and distribution of two sunscreens: a comparison between reconstituted human skin and hairless rat skin. Skin Pharmacol. Physiol. 2008, 21:318-325.
33. Korsmeyer R.W., Gurny R., Doelker E., Buri P., Peppas N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 1983, 15:25-35.
34. Ritger P.L., Peppas N.A. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Release 1987, 5:37-42.
35. Siepmann J., Peppas N.A. Modeling of drug release from delivery systems based on hydroxy-propyl methylcellulose (HPMC). Adv. Drug Deliver. Rev. 2001, 58:139-157.
36. Rinaki E., Valsami G., Macheras P. The power law can describe the "entire" drug release curve from HPMC-based matrix tablets: a hypothesis. Int. J. Pharm. 2003, 255:199-207.
37. Ranga K.V., Rao, Devi P., Buri P. Cellulose matrices for zero-order release of soluble drugs. Drug Dev. Ind. Pharm. 1988, 14:2299-2320.
38. Ferrero C., Muñoz-Ruiz A., Jiménez-Castellano M.R. Fronts movements as a useful tool for hydrophilic matrix release mechanism elucidation. Int. J. Pharm. 2000, 202:21-28.
39. Sato H., Sugibayashi K., Morimoto Y. Spesies differences in percutaneous absorption of nicoradil. J. Pharm. Sci. 1991, 80:104-107.
40. Monteiro-Riviere N.A., Bristol D.G., Manning T.O., Rogers R.A., Riviere J.E. Interspecies and interregional analysis of the comparative histologic thickness and laser doppler blood flow measurements at five cutaneous sites in nine species. J. Invest. Dermatol. 1990, 95:582-586.
41. van Ravenzwaay B., Leibold E. The significance of in vitro rat skin absorption studies to human risk assessment. Toxicol. In Vitro 2004, 18:219-225.
42. Al-Saidan S.M. Transdermal self-permeation enhancement of ibuprofen. J. Control. Release 2004, 24:199-209.
43. Korinth G., Goen T., Schaller K.H., Drexler H. Discrepancies between different rat models for the assessment of percutaneous penetration of hazardous substances. Arch. Toxicol. 2007, 81:833-840.
44. Irwin W.J., Sanderson F.D., Li Wan Po A. Percutaneous absorption of ibuprofen: vehicle effects on transport through rat skin. Int. J. Pharm. 1990, 66:193-200.
45. Park E.S., Chang S.Y., Hahn M., Chi S.C. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int. J. Pharm. 2000, 209:109-119.
46. Gonzales N., Sumano H. Design of two liquid ibuprofen-poloxamer-limonene or menthol preparations for dermal administration. Drug Deliv. 2007, 14:287-293.
47. Carafa M., Marianecci C., Rinaldi F., Santucci E., Tampucci S., Monti D. Span and Tween neutral and pH-sensitive vesicles: characterization and in vitro skin permeation. J. Lipos. Res. 2009, 19:332-340.
48. Goldberg-Cettina M., Liu P., Nightingale J., Kurihara-Bergstrom T. Enhanced transdermal delivery of estradiol in vitro using binary vehicles of isopropyl myristate and short-chain alkanols. Int. J. Pharm. 1995, 14:237-245.
49. Williams A.C., Barry B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 2004, 56:603-618.
50. Watkinson A.C., Brain K.R., Walters K.A. The penetration of ibuprofen through human skin in vitro: vehicle enhancer and pH effects. Prediction of Percutaneous Absorption 1993, vol. 3B:335-341. STS Publishing, Cardiff.
51. Scott P.W., William A.C., Barry B.W. Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J. Control. Release 1998, 50:297-308.
52. Brain K.R., Green D.M., Dykes P.J., Marks R., Bola T.S. The role of menthol in skin penetration from topical formulations of ibuprofen 5% in vivo. Skin Pharmacol. Physiol. 2006, 19:17-21.
53. Santi P., Nicoli S., Colombo G., Bettini R., Artusi M., Rimondi S., Padula C., Rizzo P., Colombo P. Post-ionthophoresis transport of ibuprofen lysine across rabbit ear skin. Int. J. Pharm. 2003, 266:69-75.
54. Marimoto Y., Hayashi T., Kawabata S., Seki T., Sugibashi K. Effect of 1-menthol-ethanol system on the systemic absorption of flubiprofen after repeated topical application in rabbits. Biol. Pharm. Bull. 2000, 23:1254-1257.
55. Katayama K., Matsui R., Hatanada T., Koizumi T. Effect of pH on skin permeation enhancement of acidic drugs by 1-menthol-ethanol system. Int. J. Pharm. 2001, 226:69-80.
56. Herkenne C., Naik A., Kalia Y.N., Hadgraft J., Guy R. Effect of prolylene glycol on ibuprofen absorption into human skin in vivo. J. Pharm. Sci. 2008, 97:185-197.